GOSEMDI Trademark

Trademark Overview


On Wednesday, December 14, 2022, a trademark application was filed for GOSEMDI with the United States Patent and Trademark Office. The USPTO has given the GOSEMDI trademark a serial number of 97716658. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, November 21, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The GOSEMDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of inflammatory and autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contracep...

General Information


Serial Number97716658
Word MarkGOSEMDI
Filing DateWednesday, December 14, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of inflammatory and autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Saturday, December 17, 2022NEW APPLICATION ENTERED
Tuesday, January 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Monday, September 18, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, September 18, 2023EXAMINERS AMENDMENT E-MAILED
Monday, September 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 18, 2023EXAMINER'S AMENDMENT ENTERED
Monday, September 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 31, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 31, 2024SOU EXTENSION 1 GRANTED
Friday, May 31, 2024SOU EXTENSION 1 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 21, 2024SOU TEAS EXTENSION RECEIVED
Thursday, November 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 21, 2024SOU EXTENSION 2 FILED
Thursday, November 21, 2024SOU EXTENSION 2 GRANTED